243 filings
Page 4 of 13
8-K
dnor0y sn
4 Aug 21
CytoSorbents Reports Second Quarter 2021 Financial and Second Quarter 2021 Financial Highlights
12:00am
8-K
jf1zmv e0ut2u
27 Jul 21
Termination of a Material Definitive Agreement
5:04pm
8-K
xd6bdzbwjl
6 Jul 21
Other Events
4:10pm
8-K
wk9k65i9kcmcpebhg2p
2 Jun 21
Submission of Matters to a Vote of Security Holders
12:00am
8-K
82tkp 5a0
5 May 21
CytoSorbents Reports First Quarter 2021 Financial and Operational Results
6:03am
8-K
ete eqzxiqsmyt9zhyo
20 Apr 21
U.S. FDA Approves CytoSorbents to Initiate U.S. STAR-T Trial For Ticagrelor Removal During Cardiothoracic Surgery
4:30pm
8-K
f89n2g
15 Apr 21
Departure of Directors or Certain Officers
12:00am
8-K
9pia6mwtzlv75gc3r5
8 Apr 21
Amendments to Articles of Incorporation or Bylaws
4:50pm
8-K
umh5gqhijaibc
31 Mar 21
CytoSorbents Announces Lease of New Global Headquarters in Princeton, New Jersey
4:21pm
8-K
wk4ickryb8 snq6yt5
17 Mar 21
CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for U.S. Trial on Ticagrelor Removal During Cardiothoracic Surgery
4:30pm
8-K
ijok97mr
9 Mar 21
CytoSorbents Announces 2020 Financial and Operational Results
4:30pm
8-K
7b3a1as ubyqwe9q7h
18 Feb 21
Other Events
4:30pm
8-K
2qaid
12 Jan 21
CytoSorbents Reports Preliminary Fourth Quarter and Full Year 2020 Revenue
4:30pm
8-K
mrejad4qp9d14mwvvs
10 Dec 20
Entry into a Material Definitive Agreement
4:30pm
8-K
bxlzovm5hb6wm45jw3x
5 Nov 20
CytoSorbents Reports Record Third Quarter 2020 Financial Results
12:00am
8-K
xdcqaj8pudu gv9djbe
4 Aug 20
CytoSorbents Reports Record Second Quarter 2020 Financial Results
5:01pm
8-K
fsoszc3fhd162a
24 Jul 20
Other Events
4:08pm
8-K
1ckq4eh9
22 Jul 20
CytoSorbents Corporation Announces Pricing of $50 Million Public Offering of Common Stock
5:26pm
8-K
q38nnbnc ejge
21 Jul 20
Other Events
9:30pm
8-K
yrpl43v637
20 Jul 20
CytoSorbents Provides Preliminary Q2 2020 Financial Results and Corporate Update
4:49pm